Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
SHOC2
Description:
A human protein encoded by the SHOC2 gene that regulates MAPK signaling and is studied in cancer biology.
Primary topic:
Protein Tyrosine Phosphatases (27%)
Related topics:
Protein Tyrosine Phosphatases (27%),
Protein Kinase Regulation and GTPase Signaling (24%),
Melanoma and MAPK Pathways (8%)
Wikidata ID:
wiki/Q18032712
OpenAlex ID:
keywords/shoc2
Noonan syndrome and clinically related disorders
2011
·
Marco Tartaglia
, Bruce D. Gelb
, et al.
·
Best Practice & Research Clinical Endocrinology & Metabolism
·
463
Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair
2009
·
Viviana Cordeddu
, Elia Di Schiavi
, et al.
·
Nature Genetics
·
453
PDF
Noonan Syndrome: Clinical Aspects and Molecular Pathogenesis
2010
·
M. Tartaglia
, G. Zampino
, et al.
·
Molecular Syndromology
·
268
PDF
LRRC8 proteins share a common ancestor with pannexins, and may form hexameric channels involved in cell‐cell communication
2012
·
Federico Abascal
, Rafael Zardoya
·
BioEssays
·
169
Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis
2014
·
E. Flex
, M. Jaiswal
, et al.
·
Human Molecular Genetics
·
166
PDF
Desmoglein-1/Erbin interaction suppresses ERK activation to support epidermal differentiation
2013
·
Robert M. Harmon
, Cory L. Simpson
, et al.
·
Journal of Clinical Investigation
·
151
PDF
An MRAS, SHOC2, and SCRIB Complex Coordinates ERK Pathway Activation with Polarity and Tumorigenic Growth
2013
·
Lucy C. Young
, Nicole Hartig
, et al.
·
Molecular Cell
·
125
PDF
Clinical manifestations of mutations in RAS and related intracellular signal transduction factors
2011
·
Martin Zenker
·
Current Opinion in Pediatrics
·
106
Scribble mis-localization induces adaptive resistance to KRAS G12C inhibitors through feedback activation of MAPK signaling mediated by YAP-induced MRAS
2023
·
Yuta Adachi
, Ryo Kimura
, et al.
·
Nature Cancer
·
103
SHOC2–MRAS–PP1 complex positively regulates RAF activity and contributes to Noonan syndrome pathogenesis
2018
·
Lucy C. Young
, Nicole Hartig
, et al.
·
Proceedings of the National Academy of Sciences
·
101
Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers
2019
·
Rita Sulahian
, Jason J. Kwon
, et al.
·
Cell Reports
·
96
PDF
Structure–function analysis of the SHOC2–MRAS–PP1C holophosphatase complex
2022
·
Jason J. Kwon
, Behnoush Hajian
, et al.
·
Nature
·
89
Growth standards of patients with Noonan and Noonan‐like syndromes with mutations in the RAS/MAPK pathway
2012
·
Alexsandra C. Malaquias
, Amanda S. Brasil
, et al.
·
American Journal of Medical Genetics Part A
·
84
PDF
Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance
2024
·
Venu Thatikonda
, Hengyu Lyu
, et al.
·
Nature Cancer
·
83
PDF
Mutation analysis of the SHOC2 gene in Noonan-like syndrome and in hematologic malignancies
2010
·
Shoko Komatsuzaki
, Yoko Aoki
, et al.
·
Journal of Human Genetics
·
65
Structural basis for SHOC2 modulation of RAS signalling
2022
·
Nicholas P. D. Liau
, Matthew C. Johnson
, et al.
·
Nature
·
62
PDF
SHOC2 and CRAF Mediate ERK1/2 Reactivation in Mutant NRAS-mediated Resistance to RAF Inhibitor
2012
·
Fred M. Kaplan
, Curtis H. Kugel
, et al.
·
Journal of Biological Chemistry
·
61
PDF
MRAS: A Close but Understudied Member of the RAS Family
2018
·
Lucy C. Young
, Pablo Rodriguez-Viciana
·
Cold Spring Harbor Perspectives in Medicine
·
60
PDF
Structure of the SHOC2–MRAS–PP1C complex provides insights into RAF activation and Noonan syndrome
2022
·
Daniel A. Bonsor
, Patrick Alexander
, et al.
·
Nature Structural & Molecular Biology
·
59
PDF
Structure of the MRAS–SHOC2–PP1C phosphatase complex
2022
·
Zachary J. Hauseman
, Michelle Fodor
, et al.
·
Nature
·
56
PDF
Molecular and phenotypic spectrum of Noonan syndrome in Chinese patients
2019
·
Xin Li
, Ruen Yao
, et al.
·
Clinical Genetics
·
56
Ras/MAPK syndromes and childhood hemato-oncological diseases
2012
·
Yoko Aoki
, Yoichi Matsubara
·
International Journal of Hematology
·
54
PDF
Activating MRAS mutations cause Noonan syndrome associated with hypertrophic cardiomyopathy
2019
·
Marialetizia Motta
, Lena Sagi-Dain
, et al.
·
Human Molecular Genetics
·
53
External ear anomalies and hearing impairment in Noonan Syndrome
2015
·
Dorothée C. van Trier
, Josephine van Nierop
, et al.
·
International Journal of Pediatric Otorhinolaryngology
·
50
SHOC2 complex-driven RAF dimerization selectively contributes to ERK pathway dynamics
2019
·
Isabel Boned del Río
, Lucy C. Young
, et al.
·
Proceedings of the National Academy of Sciences
·
49
PDF
Show more works
View as search
Works count:
273
Citation count:
4,979
Year
Topic
Type